ABBOTT BIOLOGICALS BV has a total of 49 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), Taiwan and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are DE STAAT DER NEDERLANDEN VERT DOOR DE MINI VAN VWS, SEQIRUS UK LTD and KOLON LIFE SCIENCE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Taiwan | 8 | |
#3 | Australia | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Argentina | 3 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Brazil | 2 | |
#9 | Canada | 2 | |
#10 | Hong Kong | 2 | |
#11 | Mexico | 2 | |
#12 | Russian Federation | 2 | |
#13 | Israel | 1 | |
#14 | Japan | 1 | |
#15 | Malaysia | 1 | |
#16 | Ukraine | 1 | |
#17 | United States | 1 | |
#18 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Fouchier Ron A M | 12 |
#2 | Spronken Monique I J | 12 |
#3 | Osterhaus Albert D M E | 11 |
#4 | Medema Jeroen Kristiaan | 10 |
#5 | Kersten Alexander Jeroen | 10 |
#6 | Kersten Alexander J | 10 |
#7 | Thus Johannes Lambertus Gerardus | 10 |
#8 | Schoen Pieter Joseph | 9 |
#9 | Shaker Sabah | 7 |
#10 | Thus Jo | 7 |
Publication | Filing date | Title |
---|---|---|
WO2013010797A1 | Process for producing viral antigen and vaccines | |
AU2011204881A1 | Rescue of influenza virus | |
TW201202425A | Production of viral components | |
TW201103980A | Viral vaccine and use thereof | |
BRPI1012079A2 | A method for treating foreign agents in a composition, uses a polynucleotide construct, an elevated antibody against an expression product of a polynucleotide construct, and a part kit, and process for producing a pharmaceutical composition. | |
TW201738562A | Extraneous agents testing | |
EP2207031A1 | Adjuvant testing for vaccine preparations | |
EP2158921A1 | Intranasal influenza vaccine based on virosomes | |
TW200808345A | Intranasal or inhalational administration of virosomes | |
CN101379183A | Rescue of influenza virus | |
EP2272950A2 | Defective influenza virus particles |